Disialoganglioside GD2 expression in solid tumors and role as a target for cancer therapy

B Nazha, C Inal, TK Owonikoko - Frontiers in Oncology, 2020 - frontiersin.org
Gangliosides are carbohydrate-containing sphingolipids that are widely expressed in
normal tissues, making most subtypes unsuitable as targets for cancer therapy. However …

The biological role and immunotherapy of gangliosides and GD3 synthase in cancers

S Cao, X Hu, S Ren, Y Wang, Y Shao, K Wu… - Frontiers in Cell and …, 2023 - frontiersin.org
Gangliosides are a large subfamily of glycosphingolipids that broadly exist in the nervous
system and interact with signaling molecules in the lipid rafts. GD3 and GD2 are two types of …

Epithelial ovarian cancer: A five year review

C Arnaoutoglou, K Dampala, C Anthoulakis… - Medicina, 2023 - mdpi.com
Ovarian cancer is a malignant disease that affects thousands of patients every year.
Currently, we use surgical techniques for early-stage cancer and chemotherapy treatment …

Bioactive sphingolipids as emerging targets for signal transduction in cancer development

W Jia, J Yuan, J Zhang, S Li, W Lin, B Cheng - Biochimica et Biophysica …, 2024 - Elsevier
Sphingolipids, crucial components of cellular membranes, play a vital role in maintaining
cellular structure and signaling integrity. Disruptions in sphingolipid metabolism are …

Ganglioside GD2 enhances the malignant phenotypes of melanoma cells by cooperating with integrins

F Yesmin, RH Bhuiyan, Y Ohmi, S Yamamoto… - International journal of …, 2021 - mdpi.com
Gangliosides have been considered to modulate cell signals in the microdomain of the cell
membrane, lipid/rafts, or glycolipid-enriched microdomain/rafts (GEM/rafts). In particular …

Expression patterns and clinical significance of the potential cancer stem cell markers OCT4 and NANOG in colorectal cancer patients

R Roudi, M Barodabi, Z Madjd, G Roviello… - Molecular & Cellular …, 2020 - Taylor & Francis
Colorectal cancer (CRC) is one of the most important malignancies and causes of cancer-
related deaths worldwide. Cancer stem cell markers identification could be helpful to acquire …

[HTML][HTML] Anti-GD2 antibody dinutuximab inhibits triple-negative breast tumor growth by targeting GD2+ breast cancer stem-like cells

S Ly, V Anand, F El-Dana, K Nguyen, Y Cai… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
Background Triple-negative breast cancer (TNBC) is the most aggressive breast cancer
subtype with no effective standard therapy. Breast cancer stem-like cells (BCSCs) in primary …

GD2-Targeting CAR T-cell Therapy for Patients with GD2+ Medulloblastoma

R Ciccone, C Quintarelli, A Camera, M Pezzella… - Clinical Cancer …, 2024 - AACR
Abstract Purpose: Medulloblastoma (MB), the most common childhood malignant brain
tumor, has a poor prognosis in about 30% of patients. The current standard of care, which …

In-depth characterization of a new patient-derived xenograft model for metaplastic breast carcinoma to identify viable biologic targets and patterns of matrix evolution …

MD Matossian, T Chang, MK Wright, HE Burks… - Clinical and …, 2022 - Springer
Metaplastic breast carcinoma (MBC) is a rare breast cancer subtype with rapid growth, high
rates of metastasis, recurrence and drug resistance, and diverse molecular and histological …

Differences in PD-L1 Expression between oral and oropharyngeal squamous cell carcinoma

S Blatt, M Krüger, C Rump, S Zimmer, K Sagheb… - PLoS …, 2022 - journals.plos.org
Treatment of metastasized or recurrent oral (OSCC) and oropharyngeal (OPSCC) squamous
cell carcinoma remains challenging. Targeted antibody-based therapy inter alia for PD-1/PD …